Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study).

Autor: Castillo-López IY; Otolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico. irma.castillol@imss.gob.mx., Govea-Camacho LH; Otolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico., Rodríguez-Torres IA; Area of Chronic Disease and Cancer Detection, Primary Comprehensive Healthcare Administration, IMSS, Mexico City, Mexico., Recio-Macías DA; Otolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico., Alobid I; Rhinology Unit and Smell Clinic, Otorhinolaryngology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.; Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Barcelona, Catalonia, Spain., Mullol J; Rhinology Unit and Smell Clinic, Otorhinolaryngology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain. jmullol@clinic.cat.; Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Barcelona, Catalonia, Spain. jmullol@clinic.cat.; ENT Department, Hospital Clinic Barcelona-IDIBAPS, Villarroel 170, 08036, Barcelona, Catalonia, Spain. jmullol@clinic.cat.

Publikováno v: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2020 Nov 08; Vol. 20 (12), pp. 78. Date of Electronic Publication: 2020 Nov 08.